AMEAMETEK, Inc.
AMETEK, Inc. (AME) is a diversified manufacturer of medical devices, diagnostic equipment, and industrial automation systems, with a strong presence in the health care equipment and supplies sector. The next catalyst for AME is Nov 5, 2026 — Q3 2026 Earnings Release, which will test the sustainability of recent revenue growth and the impact of macroeconomic pressures on its core business.
- AME’s revenue grew 6.6% YoY in the most recent quarter, driven by strong performance in its medical and industrial segments.
- The company maintains a net margin of 20.1% (TTM), with a debt-to-equity ratio of 0.24x, reflecting a disciplined capital structure.
- AME’s share price has historically shown resilience, with a 5% rise following strong Q4 2025 results and a strategic acquisition.
The Read
5% on strong Q4 2025 results and a strategic acquisition, then rose 0%.
The schedule
- Tue3Nov
Q3 2026 Earnings Release and Guidance
- Tue9Feb
- Thu29Apr
- Tue3Aug
Past
- Tue4Aug
Actual outcome: Bull · $253.66 at outcome
AME reported earnings in line with estimates, but the company raised full-year guidance and highlighted strong organic growth and margin expansion. The positive forward outlook and strategic updates reinforced investor confidence, driving the stock toward the bull target.
- Thu30Apr
Actual outcome: Mixed · $232.40 at outcome
AMETEK delivered strong Q1 2026 results, beating earnings estimates and raising its full-year guidance, while also announcing major strategic moves including the $5 billion acquisition of Indicor Instrumentation. Despite these positive fundamental developments, the stock's reaction was muted, rising just 0.8% over the outcome period and failing to reach the bull target.
- Tue17Feb
Actual outcome: Bull · $231.91 at outcome
AMETEK delivered a strong bull outcome, reporting record Q4 sales and beating consensus estimates for both EPS ($2.01 vs $1.94) and revenue, driven by 5% organic sales growth. The results confirmed robust performance across both operating segments, satisfying the market's demand for strong growth to justify the high P/E. This fundamental strength, coupled with the strategic acquisition of LKC Technologies, propelled the stock past the $227.50 bull target.
